Harrington Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.4M | Sell |
18,980
-495
| -3% | -$65.2K | 1.16% | 33 |
|
|
2026
Q1 | $2.71M | Buy |
19,475
+10
| +0.1% | +$1.4K | 1.43% | 24 |
|
|
2025
Q4 | $2.39M | Sell |
19,465
-348
| -2% | -$42.3K | 1.2% | 29 |
|
|
2025
Q3 | $2.2M | Sell |
19,813
-110
| -0.6% | -$12.5K | 1.1% | 29 |
|
|
2025
Q2 | $2.21M | Sell |
19,923
-120
| -0.6% | -$12.8K | 1.17% | 29 |
|
|
2025
Q1 | $2.25M | Buy |
20,043
+241
| +1% | +$24.9K | 1.28% | 27 |
|
|
2024
Q4 | $1.83M | Sell |
19,802
-1,575
| -7% | -$142K | 1.01% | 34 |
|
|
2024
Q3 | $1.79M | Sell |
21,377
-530
| -2% | -$40.4K | 0.98% | 38 |
|
|
2024
Q2 | $1.5M | Buy |
21,907
+40
| +0.2% | +$2.67K | 0.85% | 40 |
|
|
2024
Q1 | $1.6M | Buy |
21,867
+1,021
| +5% | +$78.5K | 0.92% | 40 |
|
|
2023
Q4 | $1.69M | Buy |
20,846
+60
| +0.3% | +$4.67K | 1.05% | 36 |
|
|
2023
Q3 | $1.56M | Buy |
20,786
+450
| +2% | +$34.6K | 1.07% | 34 |
|
|
2023
Q2 | $1.57M | Buy |
20,336
+80
| +0.4% | +$6.38K | 1.03% | 35 |
|
|
2023
Q1 | $1.68M | Buy |
20,256
+1,150
| +6% | +$95.2K | 1.16% | 31 |
|
|
2022
Q4 | $1.64M | Sell |
19,106
-450
| -2% | -$35.6K | 1.19% | 33 |
|
|
2022
Q3 | $1.21M | Buy |
19,556
+650
| +3% | +$41K | 0.94% | 39 |
|
|
2022
Q2 | $1.17M | Sell |
18,906
-1,344
| -7% | -$83.2K | 0.87% | 41 |
|
|
2022
Q1 | $1.2M | Buy |
20,250
+85
| +0.4% | +$5.43K | 0.72% | 44 |
|
|
2021
Q4 | $1.46M | Buy |
20,165
+24
| +0.1% | +$1.65K | 0.79% | 38 |
|
|
2021
Q3 | $1.41M | Sell |
20,141
-125
| -0.6% | -$8.78K | 0.81% | 40 |
|
|
2021
Q2 | $1.4M | Buy |
20,266
+206
| +1% | +$13.8K | 0.83% | 41 |
|
|
2021
Q1 | $1.3M | Buy |
20,060
+98
| +0.5% | +$6.32K | 0.81% | 40 |
|
|
2020
Q4 | $1.16M | Sell |
19,962
-1,587
| -7% | -$95.8K | 0.77% | 43 |
|
|
2020
Q3 | $1.36M | Sell |
21,549
-3,185
| -13% | -$221K | 0.96% | 36 |
|
|
2020
Q2 | $1.9M | Buy |
24,734
+3,715
| +18% | +$285K | 1.48% | 23 |
|
|
2020
Q1 | $1.57M | Sell |
21,019
-399
| -2% | -$27.6K | 1.47% | 26 |
|
|
2019
Q4 | $1.39M | Sell |
21,418
-498
| -2% | -$32.4K | 1.08% | 35 |
|
|
2019
Q3 | $1.39M | Sell |
21,916
-301
| -1% | -$19.7K | 1.14% | 36 |
|
|
2019
Q2 | $1.5M | Sell |
22,217
-221
| -1% | -$14.5K | 1.24% | 34 |
|
|
2019
Q1 | $1.46M | Sell |
22,438
-825
| -4% | -$54.8K | 1.26% | 32 |
|
|
2018
Q4 | $1.46M | Sell |
23,263
-790
| -3% | -$55.2K | 1.4% | 31 |
|
|
2018
Q3 | $1.86M | Sell |
24,053
-495
| -2% | -$37.4K | 1.47% | 30 |
|
|
2018
Q2 | $1.74M | Sell |
24,548
-135
| -0.5% | -$9.53K | 1.47% | 29 |
|
|
2018
Q1 | $1.86M | Buy |
24,683
+363
| +1% | +$28.9K | 1.53% | 25 |
|
|
2017
Q4 | $1.74M | Buy |
24,320
+1,536
| +7% | +$117K | 1.45% | 25 |
|
|
2017
Q3 | $1.85M | Buy |
+22,784
| New | +$1.74M | 1.76% | 24 |
|
Other funds holding GILD
Harrington Investments's GILD Position: Q2 2026 in Review
Harrington Investments reduced its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, selling an estimated $65.2K and leaving 18,980 shares worth $2.4M. The position accounts for 1.16% of the portfolio, ranked #33.
Harrington Investments first reported a position in GILD in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.71M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Harrington Investments held 18,980 shares of Gilead Sciences worth $2.4M as of Q2 2026.
- Harrington Investments sold 495 Gilead Sciences shares in Q2 2026, an estimated $65.2K.
- Gilead Sciences made up 1.16% of Harrington Investments's portfolio in Q2 2026, its #33 holding.
- Harrington Investments first reported a position in Gilead Sciences in Q3 2017 and has held it in 36 quarters since.
- Harrington Investments's Gilead Sciences position peaked at $2.71M in Q1 2026.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Harrington Investments's 13F filing for Q2 2026, filed 23 Jul 2026.